Global Structural Heart Devices Market Size, By Product (Heart Valves Devices(Surgical Heart Valves, Transcatheter Heart Valves), Occluders and delivery systems, Annuloplasty rings), By Procedure (Replacement procedures, Repair Procedures) By End – Users (Hospitals, Healthcare corporations, Cardiac surgery centres, Structural heart device distributors) - Global Industry Trends, Shares, Competitive Analysis and Segment Forecasts, 2018 to 2025

EXRAND050  |  Upcoming  |  Global  |  NA  |  Under Development

The structural heart diseases refer to non-coronary cardiovascular diseases. These types of diseases are cured with different types of structural heart devices such as heart valve devices, transcatheter devices, surgical heart valves and many others. Based on procedure, the structural heart devices market is segmented into replacement procedures and repair procedures. The repair procedures segment is further segmented into closure procedures, annuloplasty, valvuloplasty, and TMVR procedures, while replacement procedures the segment is divided into TAVR (transcatheter aortic valve replacement) procedures and SAVR (surgical aortic valve replacement) procedures. 

The rising prevalence of structural heart diseases, increasing rate of   approvals for new and advanced structural heart devices, favourable reimbursement scenario for structural heart procedures & devices, and increasing awareness about heart related diseases, are the major factors driving the growth of the structural heart devices market. However, low affordability and unapproachability of cardiac surgeries in some developing countries are expected to restrain the growth of structural heart devices market in future. In addition, the lack of skilled professionals may affect overall pace of market in future.

The few key players that are associated with structural heart devices market include, Edwards LifeSciences Corporation, Abbott, Medtronic plc, LivaNova plc, Boston Scientific Corporation, CryoLife Inc.,Lepu Medical Technology, TTK Healthcare Limited, Micro Interventional Devices, Inc., Braile Biomédica. 

Few companies are associated with acquisitions & new product launch; such as, on 20th January, 2016 CryoLife acquired On-X Life Technologies. On-X Life Technologies is a privately held mechanical heart valve company. On 6th December 2017, Edwards LifeSciences Corporation has acquired Harpoon Medical Inc. a privately held medical technology company. This company is a global leader in patient focused innovations related to structural heart disease and for critical care monitoring. On 30th March 2017,Boston Scientific Corporation acquired Symetis SA which is a privately held Swiss structural heart company that focuses on minimally invasive transcatheter aortic valve implantation devices and also . 

Based on the product types, the structural heart devices market has been segmented as follows:

• Heart Valves Devices

o Surgical Heart Valves

o Transcatheter Heart Valves

• Occluders and delivery systems

• Annuloplasty rings

• Others

Based on the procedures, the structural heart devices market has been segmented as follows:

• Replacement procedures

o TAVR Procedures 

o SAVR Procedures

• Repair Procedures 

o Closure Procedures

o Annuloplasty

o Valvuloplasty

o TMVR Procedures

Based on the end – users, the structural heart devices market has been segmented as follows:

• Hospitals

• Healthcare corporations

• Cardiac surgery centres

• Structural heart device distributors

• Others

Based on the geographical regions, the structural heart devices market has been segmented as follows:

• North America

o US

o Canada

o Rest of North America

• Europe

o Germany

o Italy

o UK

o France

o Rest of Europe

• Asia Pacific

o Japan

o China

o India

o Rest Of Asia Pacific

• Latin America

o Brazil

o Argentina

o Rest Of Latin America

• Middle East And Africa

o Saudi Arabia

o South Africa

o Rest Of Middle East And Africa

1. Executive Summary

2. Global Structural Heart Devices  Market Overview

2.1. Market Segmentation & Scope

2.2. Product Introduction

2.3. Market Trends

2.3.1. Introduction

2.3.2. Drivers

2.3.2.1. Rising Prevalence of Structural Heart Diseases

2.3.2.2. Increasing Awareness About Structural Heart Diseases

2.3.3. Restraint

2.3.3.1. Low Affordability and Inaccessibility of Cardiac Surgeries in Developing Countries

2.3.4. Opportunities

2.3.4.1. Percutaneous Interventions, Approval of TAVR for Extended Indications

2.3.4.2. Emergence of Tissue-Engineered Heart Valves

2.3.5. Supply Chain Analysis

2.3.6. Substitutes Threat

2.3.7. Technology Progress in Related Industry

2.3.8. Consumer Preference Analysis

3. Global Structural Heart Devices  Market by Product

3.1. Structural Heart Devices  Market Product Analysis

3.2. Global Structural Heart Devices  Market Revenue (USD Million) by Products, 2015-2025

3.2.1. Heart Valve Devices Structural Heart Devices  Market Analysis

3.2.1.1. Surgical Heart Valve Structural Heart Devices  Market Analysis

3.2.1.2. Transcatheter Heart Valve Structural Heart Devices  Market Analysis

3.2.2. Occluders and Delivery Systems Structural Heart Devices Market Analysis

3.2.3. Annuloplasty Rings Structural Heart Devices Market Analysis

3.2.4. Other Structural Heart Devices Market Analysis

3.3. List of Manufacturers, By  Structural Heart Devices  Type

4. Global Structural Heart Devices  Market by Procedure

4.1. Structural Heart Devices  Market Procedure Analysis

4.2. Global Structural Heart Devices  Market Revenue (USD Million) by Procedure, 2015-2025

4.2.1.1. TAVR Procedures

4.2.1.2. SAVR Procedures

4.2.2. Repair Procedures Market Analysis

4.2.2.1. Closure Procedures Market Analysis

4.2.2.2. Annuloplasty Market Analysis

4.2.2.3. Valvuloplasty Market Analysis

4.2.2.4. TMVR Procedures

4.3. List of Manufacturers, By Structural Heart Devices  Procedure

5. Global Structural Heart Devices  Market by End Use

5.1. Structural Heart Devices  Market End Use Analysis

5.2. Global Structural Heart Devices  Market Revenue (USD Million) by End Use, (2015-2025)

5.2.1. Hospitals Segment Analysis

5.2.2. Healthcare Corporation Segment Analysis

5.2.3. Cardiac Surgery Centres Segment Analysis

5.2.4. Structural Heart Devices Distributors Segment Analysis

5.2.5. Other Segment Analysis

5.3. List of Manufacturers, By End Use

6. Global Structural Heart Devices  Market by Region

6.1. Structural Heart Devices  Market Regional Analysis

6.2. Global Structural Heart Devices  Market Revenue (USD Million) by Region, 2015-2025

7. North America Structural Heart Devices  Market

7.1. North America Structural Heart Devices  Market Analysis

7.2. North America Structural Heart Devices  Market Revenue (USD Million), 2015-2025

7.3. North America Structural Heart Devices  by Country, 2015-2025

7.3.1. U.S. Structural Heart Devices  Market Revenue (USD Million), 2015-2025

7.3.2. Canada Structural Heart Devices  Market Revenue (USD Million), 2015-2025

7.4. Potential Buyers In North America

8. Europe Structural Heart Devices  Market

8.1. Europe Structural Heart Devices  Market Analysis

8.2. Europe Structural Heart Devices  Market Revenue (USD Million), 2015-2025

8.3. Europe Structural Heart Devices  Market by Country, 2015-2025

8.3.1. Germany Structural Heart Devices  Market Revenue (USD Million), 2015-2025

8.3.2. UK Structural Heart Devices  Market Revenue (USD Million), 2015-2025

8.3.3. France Structural Heart Devices  Market Revenue (USD Million), 2015-2025

8.3.4. Rest of Europe Structural Heart Devices  Market Revenue (USD Million), 2015-2025

8.4. Potential Buyers in Europe

9. Asia Pacific Structural Heart Devices  Market

9.1. Asia Pacific Structural Heart Devices  Market Analysis

9.2. Asia Pacific Structural Heart Devices  Market (Consumption Sales, Production Volume, and Revenue), 2015-2025

9.3. Asia Pacific Structural Heart Devices  Market, by Country, 2015-2025

9.3.1. China Structural Heart Devices  Market Revenue (USD Million), 2015-2025

9.3.2. Japan Structural Heart Devices  Market Revenue (USD Million), 2015-2025

9.3.3. India Structural Heart Devices  Market Revenue (USD Million), 2015-2025

9.3.4. Rest of Asia Pacific Structural Heart Devices  Market Revenue (USD Million), 2015-2025

9.4. Potential Buyers in Asia Pacific

10. Latin America Structural Heart Devices  Market

10.1. Latin America Structural Heart Devices  Market Analysis

10.2. Latin America Structural Heart Devices  Market Revenue (USD Million), 2015-2025

10.3. Latin America Structural Heart Devices  Market by Country, 2015-2025

10.3.1. Brazil Structural Heart Devices  Market Revenue (USD Million), 2015-2025

10.3.2. Rest of Latin America Structural Heart Devices  Market Revenue (USD Million), 2015-2025

10.4. Potential Buyers in Latin America

11. Middle East & Africa Structural Heart Devices  Market

11.1. Middle East & Africa Structural Heart Devices  Market Regional analysis

11.2. Middle East & Africa Structural Heart Devices  Market Revenue (USD Million)

11.3. Middle East & Africa Structural Heart Devices  Revenue by Country, 2015-2025

11.3.1. South Africa Structural Heart Devices  Market Revenue (USD Million), 2015-2025

11.3.2. Rest of Middle East & Africa Structural Heart Devices  Market Revenue (USD Million), 2015-2025

11.4. Potential Buyers in Middle East & Africa

12. Company Profile

12.1.  Edwards LifeSciences Corporation

12.1.1. Company Overview 

12.1.2. Financial Overview

12.1.3. Product Benchmarking

12.1.4. Key Developments

12.2. Abbott

12.2.1. Company Overview 

12.2.2. Financial Overview

12.2.3. Product Benchmarking

12.2.4. Key Developments

12.3. Medtronic plc 

12.3.1. Company Overview 

12.3.2. Financial Overview

12.3.3. Product Benchmarking

12.3.4. Key Developments

12.4. LivaNova plc 

12.4.1. Company Overview 

12.4.2. Financial Overview

12.4.3. Product Benchmarking

12.4.4. Key Developments

12.5. Boston Scientific Corporation

12.5.1. Company Overview 

12.5.2. Financial Overview

12.5.3. Product Benchmarking

12.5.4. Key Developments

12.6. CryoLife Inc.

12.6.1. Company Overview 

12.6.2. Financial Overview

12.6.3. Product Benchmarking

12.6.4. Key Developments

12.7. Lepu Medical Technology 

12.7.1. Company Overview 

12.7.2. Financial Overview

12.7.3. Product Benchmarking

12.7.4. Key Developments

12.8. TTK Healthcare Limited 

12.8.1. Company Overview 

12.8.2. Financial Overview

12.8.3. Product Benchmarking

12.8.4. Key Developments

12.9. Micro Interventional Devices Inc.

12.9.1. Company Overview 

12.9.2. Financial Overview

12.9.3. Product Benchmarking

12.9.4. Key Developments

12.10. Braile Biomédica

12.10.1. Company Overview 

12.10.2. Financial Overview

12.10.3. Product Benchmarking

12.10.4. Key Developments

13. Structural Heart Devices  Manufacturing Cost Analysis

13.1. Structural Heart Devices  Key Raw Procedures Analysis

13.1.1. Key Raw Procedures

13.1.2. Price Trend of Key Raw Procedures

13.1.3. Market Concentration Rate of Raw Procedures

13.1.4. Manufacturing Cost Structure

13.2. Marketing Strategy Analysis

13.2.1. Marketing Type Analysis

13.2.2. Pricing Strategy

13.2.3. Brand Strategy

13.2.4. Consumer Analysis

14. Key Insights

15. Research Methodology